Results 1 to 10 of about 33,657 (222)

Dengue Vaccine : what you need to know [PDF]

dengue.pdf1. Why get vaccinated? -- 2. Dengue vaccine -- 3. Talk with your health care provider -- 4. Risks of a vaccine reaction -- 5. What if there is a serious problem? -- 6.

core  

Dengue epidemiology : globally and in the United States [PDF]

02-Dengue-Adams-508 ...

core  

Analysis of the evidence about the efficacy and safety of the CYD-TDV dengue vaccine and its potential licensing and implementation within the Mexican Universal Vaccination Program

Salud Pública de México, 2016
Dengue is a major global public health problem which affects Latin America and Mexico. The prevention and control measures focusing on epidemiological surveillance and vector control have been partially effective as well as costly; thus, the development ...
Mauricio Hernández-Ávila, José Ignacio Santos-Preciado   +1 more
doaj  

Dengue Vaccine : Fact Sheet for Providers [PDF]

Dengvaxia is a live vaccine approved for use in people 9 through 16 years of age living in dengue-endemic areas, AND who have laboratory confirmation of previous dengue infection. Dengue is endemic in the U.S.

core  

TAK-003 (Tetravalent Dengue Vaccine Candidate) [PDF]

Dengue-02-Biswal-508 ...

core  

Influence of hosts on the ecology of arboviral transmission: Potential mechanisms influencing dengue, Murray Valley encephalitis, and Ross River virus in Australia

, 2009
Ecological interactions are fundamental to the transmission of infectious disease. Arboviruses are particularly elegant examples, where rich arrays of mechanisms influence transmission between vectors and hosts.
Bestall, A., Jardine, A., Carver, S., Ostfeld, R.S.   +3 more
core  

Implementation of dengue vaccine in Puerto Rico [PDF]

02-dengue-Cardona-508 ...

core  

About Dengvaxia: A Dengue Vaccine [PDF]

Dengvaxia is the first dengue vaccine available for children 9\u201316 years old who have already had dengue and live in an area where dengue is common.To learn more, visit: cdc.gov/dengueAccessible link: https://www.cdc.gov/dengue/vaccine/parents ...

core  

Dengue vaccine: an update

Expert Review of Anti-Infective Therapy, 2021
Introduction: Dengue virus is a global health threat, with approximately 390 million dengue infections annually. Efficient vaccines for dengue prevention are currently lacking. This review aims to summarize the current progress in dengue vaccine development.Area covered: This article discusses recent dengue vaccine developments based on the published ...
Chung-Hao Huang, Yu-Te Tsai, Wen-Hung Wang   +2 more
exaly   +3 more sources

Targets and strategies for vaccine development against dengue viruses

Biomedicine and Pharmacotherapy, 2021
Wen-Hung Wang, Aspiro Nayim Urbina, Chih-Yen Lin   +2 more
exaly